IL1B and metabolic dysfunction-associated steatotic liver disease: In animal models of MASLD, SB was found to increase the cecum weight and reduce the severity of intestinal villi disorganization and atrophic changes as well as the formation of TNF-α and IL-1β in the walls of the small and large intestines [24,26,29].